Clinical trial
Multimodal Interventions to Improve Adherence to Oral Tenofovir/Emtricitabine as Pre-Exposure Prophylaxis in Women in Southern California
NCT02584140 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multimodal Interventions to Improve Adherence to Oral Tenofovir/Emtricitabine as Pre-Exposure Prophylaxis in Women in Southern California
- Lead sponsor
- University of California, Los Angeles
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- May 31, 2016
- Completion date
- June 14, 2019
- Enrollment
- 136 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
hiv prevention